- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Noventa Limited Announces Approval of TSX Listing
Noventa Limited (TSE:NTA), the Mozambican miner and producer of tantalum concentrate, announced that it has received approval to list its ordinary shares on the Toronto Stock Exchange (“TSX”).
Noventa Limited (TSX:NTA), a Mozambican miner and producer of tantalum concentrate, announced that it has received approval to list its ordinary shares on the Toronto Stock Exchange (“TSX”).
The press release is quoted as saying:
The ordinary shares are scheduled to commence trading on the TSX at opening of the TSX on Thursday 23 December 2010 under the symbol “NTA”.
Eric Kohn, Chairman of Noventa, stated that:
“This listing is a fulfillment of a commitment to our shareholders and will help Noventa by listing in a jurisdiction where mining is a major activity and where rare metals and rare earths are recognised for their value.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.